Track topics on Twitter Track topics that are important to you
In a phase 2b trial, treatment with the investigational agent MIN-101 led to an improvement in negative symptoms of schizophrenia.
Medscape Medical News
Original Article: New Agent Promising for Negative Schizophrenia SymptomsNEXT ARTICLE
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...